SEC Form 4 · accession 0001123292-15-001116
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Hambleton
Officer — SVP & Chief Medical Officer
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $19.25 | Aug 17, 2015 | A | 75,000 | A | — | Aug 16, 2025 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1One forty-eighth of the shares underlying the option will vest monthly beginning on September 17, 2015.